Veltassa and Lokelma are both medications used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. They work through different mechanisms to remove excess potassium from the body.
How does Veltassa work?
Veltassa (patiromer) is an oral medication that binds to potassium in the gastrointestinal tract, preventing its absorption into the bloodstream and promoting its excretion in the stool [1].
How does Lokelma work?
Lokelma (sodium zirconium cyclosilicate) is also an oral medication that binds to potassium in the GI tract and excretes it. It works by exchanging sodium for potassium and other cations like ammonium and calcium within the lumen of the gastrointestinal tract [2].
What is the difference in how they remove potassium?
Veltassa binds to potassium and is not absorbed systemically. Lokelma, conversely, binds to potassium and also exchanges it for sodium, which is then absorbed. This difference in mechanism means Lokelma can contribute to sodium intake, which may be a consideration for patients on sodium-restricted diets [2].
When can patients expect results from these medications?
Both Veltassa and Lokelma can lower potassium levels relatively quickly. Studies have shown that Lokelma can achieve a reduction in serum potassium within the first hour of administration [2]. Veltassa also demonstrates efficacy in reducing potassium levels over time with consistent dosing [1].
Are there any differences in who can use Veltassa or Lokelma?
Both medications are indicated for the treatment of hyperkalemia in adults. However, their differing sodium content may influence prescribing decisions for patients with conditions sensitive to sodium intake, such as heart failure or kidney disease [1][2].
What are the potential side effects?
Common side effects for Veltassa include gastrointestinal issues such as diarrhea, nausea, and constipation [1]. Lokelma can also cause gastrointestinal side effects like diarrhea, nausea, and abdominal discomfort. Due to its sodium content, Lokelma may also lead to fluid retention or edema in some patients [2].
How do Veltassa and Lokelma compare on price and availability?
Information on direct cost comparisons and insurance coverage can vary. DrugPatentWatch.com tracks patent information which can influence generic availability and pricing over time. For the most current pricing and insurance coverage details, consulting with a healthcare provider or pharmacist is recommended.
What are the patent and exclusivity statuses of these drugs?
Information regarding patents and market exclusivity for Veltassa and Lokelma can be found through resources like DrugPatentWatch.com. This data is crucial for understanding when generic versions might become available.
Sources:
[1] https://www.drugpatentwatch.com/drug/veltassa
[2] https://www.drugpatentwatch.com/drug/lokelma